Search hospitals > Florida > Jacksonville
Clinical Neuroscience Solutions, Inc
Claim this profileJacksonville, Florida 32256
Global Leader in Depression
Global Leader in Attention Deficit Hyperactivity Disorder (ADHD)
Conducts research for Major Depressive Disorder
Conducts research for Migraine
Conducts research for Alzheimer's Disease
186 reported clinical trials
4 medical researchers
Summary
Clinical Neuroscience Solutions, Inc is a medical facility located in Jacksonville, Florida. This center is recognized for care of Depression, Attention Deficit Hyperactivity Disorder (ADHD), Major Depressive Disorder, Migraine, Alzheimer's Disease and other specialties. Clinical Neuroscience Solutions, Inc is involved with conducting 186 clinical trials across 79 conditions. There are 4 research doctors associated with this hospital, such as Nandita Jones, Nandita Joshi Jones, John Mark Joyce, and John Joyce.Top PIs
Nandita JonesClinical Neuroscience Solutions Inc3 years of reported clinical research
Studies Migraine
Studies Attention Deficit Hyperactivity Disorder (ADHD)
7 reported clinical trials
5 drugs studied
Nandita Joshi JonesClinical Neuroscience Solutions Inc4 years of reported clinical research
Studies Migraine
Studies Attention Deficit Hyperactivity Disorder (ADHD)
5 reported clinical trials
5 drugs studied
John Mark JoyceCNS Healthcare - Jacksonville1 year of reported clinical research
Studies Alzheimer's Disease
Studies Depression
3 reported clinical trials
4 drugs studied
John JoyceClinical Neuroscience Solutions, Inc2 years of reported clinical research
Studies Depression
Studies Major Depressive Disorder
2 reported clinical trials
4 drugs studied
Clinical Trials running at Clinical Neuroscience Solutions, Inc
Migraine
Depression
Coronavirus
Attention Deficit Hyperactivity Disorder (ADHD)
Major Depressive Disorder
COVID-19
Bipolar Disorder
Dementia
Alzheimer's Disease
Psychomotor Agitation
Lasmiditan
for Pediatric Migraine
The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.
Recruiting2 awards Phase 3
Galcanezumab
for Migraine
The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.
Recruiting1 award Phase 31 criteria
Lasmiditan
for Pediatric Migraine
This trial is testing if lasmiditan is safe and effective for children aged 6 to 17 with migraines. The medication aims to block brain signals that cause migraine pain. The study will last several months and may include a few visits. Lasmiditan has been shown to be effective in treating acute migraine attacks in adults and is noted for its safety profile, particularly due to its lack of vasoconstrictive effects.
Recruiting1 award Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Clinical Neuroscience Solutions, Inc?
Clinical Neuroscience Solutions, Inc is a medical facility located in Jacksonville, Florida. This center is recognized for care of Depression, Attention Deficit Hyperactivity Disorder (ADHD), Major Depressive Disorder, Migraine, Alzheimer's Disease and other specialties. Clinical Neuroscience Solutions, Inc is involved with conducting 186 clinical trials across 79 conditions. There are 4 research doctors associated with this hospital, such as Nandita Jones, Nandita Joshi Jones, John Mark Joyce, and John Joyce.